Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas.

By De Leo V   Morgante G   Lanzetta D   D'Antona D   Bertieri R S  

Human Reproduction, Vol. 12, Iss. 2, 1997-02 ,pp. : 357-360

Oxford University Press

Access to resources Recommend Favorite

Endometrial ultrasonography as a predictor of pregnancy in an in-vitro fertilization programme after ovarian stimulation and gonadotrophin-releasing hormone and gonadotrophins

By Oliveira J.B.A.   Baruffi R.L.R.   Mauri A.L.   Petersen C.G.   Borges M.C.   Franco J.G.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2515-2518

Oxford University Press

Access to resources Recommend Favorite

Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.

By Cheung A P   Lu J K   Chang R J  

Human Reproduction, Vol. 12, Iss. 6, 1997-06 ,pp. : 1156-1164

Oxford University Press

Access to resources Recommend Favorite

Effect of profound suppression of luteinizing hormone during treatment with gonadotrophin-releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos

By Rekha P   Mowat L   Jamieson ME   Yates RWS   Fleming R  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 696-698

Oxford University Press

Access to resources Recommend Favorite

A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study

By Dada T   Salha O   Baillie HS   Sharma V  

Human Reproduction, Vol. 14, Iss. 2, 1999-02 ,pp. : 288-293

Oxford University Press

Access to resources Recommend Favorite